Idiopathic thrombocytopenic purpura diagnosed during the second decade of life
- PMID: 12183723
- DOI: 10.1067/mpd.2002.125909
Idiopathic thrombocytopenic purpura diagnosed during the second decade of life
Abstract
Objective: To retrospectively review our institutional experience of adolescents with idiopathic thrombocytopenic purpura (ITP).
Study design: Medical record review of all patients diagnosed with ITP between the ages of 10 and 18 years seen at our center from January 1976 to March 2000.
Results: Data were collected from 126 patients. Of the evaluable 110 cases, 63 (57%) satisfied the criteria for chronic ITP, 30 (27%) for acute ITP, and 17 (15%) were uncertain. Sex distribution and mean ages were similar in all 3 groups. Platelet count at presentation was higher in patients with chronic ITP. Splenectomy was performed in 24 patients, with 17 (77%) of 22 having normal platelet counts at last follow-up. Outcome for the nonsplenectomized patients with chronic ITP included normalization of platelet count (n = 4), minimal or no bleeding without treatment (n = 29), treatment for ongoing symptoms (n = 5), and unknown (n = 1). Two patients died, 1 from intracranial hemorrhage and 1 from Escherichia coli sepsis and pulmonary hemorrhage.
Conclusions: Patients 10 to 18 years of age with ITP are more likely than younger children to have chronic disease. Many patients with ITP recover without drug therapy or need for splenectomy. ITP in adolescents shares features of both childhood and adult ITP.
Similar articles
-
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802. Clin Pediatr (Phila). 2004. PMID: 15494875
-
First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.Eur J Haematol Suppl. 2008 Feb;(69):19-26. doi: 10.1111/j.1600-0609.2007.01000.x. Eur J Haematol Suppl. 2008. PMID: 18211569 Review.
-
Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.Ann Hematol. 2002 Aug;81(8):436-40. doi: 10.1007/s00277-002-0488-x. Epub 2002 Jul 26. Ann Hematol. 2002. PMID: 12224000
-
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.Haematologica. 2005 Jan;90(1):72-7. Haematologica. 2005. PMID: 15642672
-
Management of adult idiopathic thrombocytopenic purpura.Clin Adv Hematol Oncol. 2006 Feb;4(2):136-44, 153. Clin Adv Hematol Oncol. 2006. PMID: 16728922 Review.
Cited by
-
Clinical practice: immune thrombocytopenia in paediatrics.Eur J Pediatr. 2014 Feb;173(2):163-72. doi: 10.1007/s00431-013-2254-6. Epub 2014 Jan 5. Eur J Pediatr. 2014. PMID: 24390128 Review.
-
The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.Front Pediatr. 2017 Aug 21;5:179. doi: 10.3389/fped.2017.00179. eCollection 2017. Front Pediatr. 2017. PMID: 28871277 Free PMC article. Review.
-
Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.Blood Adv. 2024 Dec 24;8(24):6183-6194. doi: 10.1182/bloodadvances.2024014381. Blood Adv. 2024. PMID: 39374586 Free PMC article.
-
Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia.Int J Hematol. 2023 May;117(5):774-780. doi: 10.1007/s12185-022-03529-z. Epub 2023 Jan 9. Int J Hematol. 2023. PMID: 36622550
-
Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis.Adv Hematol. 2017;2017:7878605. doi: 10.1155/2017/7878605. Epub 2017 Dec 6. Adv Hematol. 2017. PMID: 29362564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources